Aims: Drug eluting stents (DES) are under scrutiny for late stent thrombosis. Impaired re-endothelialisation is proposed as an explanation but coronary and peripheral-artery models disagree
1. Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands; 2. Division of Pharmacology, Vascular and Metabolic Diseases, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands; 3. Interuniversity Cardiology Institute of the Neth
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
tacrolimus-sirolimus-paclitaxel-drug-eluting stentsdelayed healingneointimastent thrombosisendotheliummicrocirculationnitric oxide
Read next articlePolymer-free cerivastatin-eluting stent shows superior neointimal inhibition with preserved vasomotor function compared to polymer-based paclitaxel-eluting stent in rabbit iliac arteries